bpc 157 human clinical trials randomized Frontiers BPC-157: What Research Shows (and
Description
Peptides are not on these standard panels
Cell, 148(6), 11451159
&srotate=0)
Gut-brain communication in demyelinating disorders
Cancer history / active malignancy: compounds that promote angiogenesis and cell migration (BPC-157, TB-500) are generally treated as contraindicated where uncontrolled cell growth is a concern a standard caution across the recovery-peptide literature
